KANSAS CITY, Mo. — Millions of people are now allowed to join a class action lawsuit regarding the higher price of EpiPens.
A U.S. District Judge in Kansas City, Kansas, moved the federal racketeering lawsuit forward. It allows anyone in the United States who paid for or provided reimbursement for EpiPens since Aug. 24, 2011, to join.
Customers can also take part in the state antitrust damages class action lawsuit if they purchased EpiPens since Jan. 28, 2013. That lawsuit includes Kansas, not Missouri.
The EpiPen is used as an emergency treatment for severe allergic reactions.
Mylan, the company that sells the EpiPen, was criticized in 2016 for raising the price from $100 to $600 for a two-pack.
The criticism led to the CEO of the company being forced to answer questions before a congressional panel about the price hike.
Back in 2018, the U.S. Food and Drug Administration approved the first generic competitor to the EpiPen to help give consumers a cheaper option.
The generic version will cost you around $300.
